This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gale RP, Bortin MM, van Bekkum DW, Biggs JC, Dicke KA, Gluckman E et al. Risk factors for acute graft-versus-host disease. Br J Haematol 1987; 67: 397–406.
Nash RA, Pepe MS, Storb R, Longton G, Pettinger M, Anasetti C et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate. Blood 1992; 80: 1838–1845.
The international non-Hodgkin's lymphoma prognostic factors project. A predictive model for the aggressive non-Hodgkin's lymphoma. N Eng J Med 1993; 329: 987–994.
Gratwohl A, Hermans J, Goldman JM, Arcese W, Carreras E, Devergie A et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Lancet 1998; 52: 1087–1092.
Gorin NC, Labopin M, Polge E, Cordonnier C, Jouet JP, Michallet M et al. Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation. Leukemia 2003; 17: 1596–1599.
Kolb HJ, Schattenberg A, Goldman J, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 1995; 86: 2041–2050.
Acknowledgements
This study has been financed in part by Grant FIS PI020148 from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III. Ministerio de Sanidad y Consumo.
Author information
Authors and Affiliations
Corresponding author
Additional information
On behalf of the Spanish Group of Hemopoietic Transplant (GETH).
Rights and permissions
About this article
Cite this article
Gallardo, D., De la Cámara, R., Torres, A. et al. Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation. Leukemia 18, 1031–1034 (2004). https://doi.org/10.1038/sj.leu.2403344
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403344